- Home
- TCRX vs ASPC Comparison
TCRX vs ASPC Comparison
Compare TCRX & ASPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- ASPC
- Stock Information
- Founded
- TCRX 2018
- ASPC 2024
- Country
- TCRX United States
- ASPC Hong Kong
- Employees
- TCRX N/A
- ASPC N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- ASPC
- Sector
- TCRX Health Care
- ASPC
- Exchange
- TCRX Nasdaq
- ASPC Nasdaq
- Market Cap
- TCRX 67.9M
- ASPC 80.9M
- IPO Year
- TCRX 2021
- ASPC 2024
- Fundamental
- Price
- TCRX $1.44
- ASPC N/A
- Analyst Decision
- TCRX Strong Buy
- ASPC
- Analyst Count
- TCRX 6
- ASPC 0
- Target Price
- TCRX $9.83
- ASPC N/A
- AVG Volume (30 Days)
- TCRX 520.8K
- ASPC 10.1K
- Earning Date
- TCRX 05-12-2025
- ASPC 01-01-0001
- Dividend Yield
- TCRX N/A
- ASPC N/A
- EPS Growth
- TCRX N/A
- ASPC N/A
- EPS
- TCRX N/A
- ASPC N/A
- Revenue
- TCRX $2,816,000.00
- ASPC N/A
- Revenue This Year
- TCRX $47.30
- ASPC N/A
- Revenue Next Year
- TCRX $74.30
- ASPC N/A
- P/E Ratio
- TCRX N/A
- ASPC N/A
- Revenue Growth
- TCRX N/A
- ASPC N/A
- 52 Week Low
- TCRX $1.02
- ASPC $9.95
- 52 Week High
- TCRX $9.69
- ASPC $10.51
- Technical
- Relative Strength Index (RSI)
- TCRX 49.74
- ASPC N/A
- Support Level
- TCRX $1.02
- ASPC N/A
- Resistance Level
- TCRX $1.36
- ASPC N/A
- Average True Range (ATR)
- TCRX 0.16
- ASPC 0.00
- MACD
- TCRX 0.05
- ASPC 0.00
- Stochastic Oscillator
- TCRX 77.78
- ASPC 0.00
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About ASPC A SPAC III Acquisition Corp. Class A Ordinary Shares
A SPAC III Acquisition Corp is a blank check company.